Methods in Molecular Biology
Series Editor
John M. Walker
School of Life and Medical Sciences, University of Hertfordshire, Hat ield, Hertfordshire, UK
For further volumes: http://www.springer.com/series/7651
For over 35 years, biological scientists have come to rely on the research protocols and methodologies in the critically acclaimed Methods in Molecular Biology series. The series was the irst to introduce the step-by-step protocols approach that has become the standard in all biomedical protocol publishing. Each protocol is provided in readily-reproducible step-by-step fashion, opening with an introductory overview, a list of the materials and reagents needed to complete the experiment, and followed by a detailed procedure that is supported with a helpful notes section offering tips and tricks of the trade as well as troubleshooting advice. These hallmark features were introduced by series editor Dr. John Walker and constitute the key ingredient in each and every volume of the Methods in Molecular Biology series. Tested and trusted, comprehensive and reliable, all protocols from the series are indexed in PubMed.
Editor
Jeffrey Carl Braman
Synthetic Biology
Methods and Protocols
2nd ed. 2024
Editor
Jeffrey Carl Braman
Agilent Technologies, Inc, La Jolla, CA, USA
ISSN 1064-3745 e-ISSN 1940-6029
Methods in Molecular Biology
ISBN 978-1-0716-3657-2 e-ISBN 978-1-0716-3658-9
https://doi.org/10.1007/978-1-0716-3658-9
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature 2024
This work is subject to copyright. All rights are solely and exclusively licensed by the Publisher, whether the whole or part of the material is concerned, speci ically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on micro ilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed.
The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a speci ic statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use.
The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have
been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional af iliations.
This Humana imprint is published by the registered company Springer Science+Business Media, LLC, part of Springer Nature. The registered company address is: 1 New York Plaza, New York, NY 10004, U.S.A.
Preface
Synthetic Biology represents a unique branch of science requiring the expertise of chemists, biologists, and engineers. This broad statement is intended to entice biochemists, analytical and organic chemists, chemical engineers, molecular biologists, computer scientists, software, mechanical, and electrical engineers, biophysicists, plant and evolutionary biologists, process and manufacturing engineers, and pharmaceutical scientists into research programs and collaborations that will solve dif icult problems such as producing renewable energy resources, feeding an ever-increasing world population, and curing disease, to name just a few examples.
The second edition of Synthetic Biology complements and enhances the irst edition and provides you with updated and enhanced techniques and tools. As with the irst edition, experienced contributors to the second edition have previously published their work in reputable, peer-reviewed periodicals, and their contributions to this second edition provide expert step-by-step guidance and ideas for conducting your own synthetic biology research.
Jeffrey Carl Braman
Contents
Part I Gene Circuits and Biochemical Pathways
1 Plant Engineering to Enable Platforms for Sustainable Bioproduction of Terpenoids
Jacob D. Bibik and Bjorn Hamberger
2 Compartmentalized Terpenoid Production in Plants Using Agrobacterium-Mediated Transient Expression
Jacob D. Bibik, Abigail E. Bryson and Bjorn Hamberger
3 Design Principles for Biological Adaptation: A Systems and Control-Theoretic Treatment
Priyan Bhattacharya, Karthik Raman and Arun K. Tangirala
4 Construction of Xylose-Utilizing Cyanobacterial Chassis for Bioproduction Under Photomixotrophic Conditions
Xinyu Song, Yue Ju, Lei Chen and Weiwen Zhang
5 Allosteric-Regulation-Based DNA Circuits in Saccharomyces cerevisiae to Detect Organic Acids and Monitor Hydrocarbon Metabolism In Vitro
Michael Dare Asemoloye and Mario Andrea Marchisio
6 dCas12a:Pre-crRNA: A New Tool to Induce mRNA Degradation in Saccharomyces cerevisiae Synthetic Gene Circuits
Lifang Yu and Mario Andrea Marchisio
Part II Genome Editing and Modi ication
7 CRISPRi-Driven Genetic Screening for Designing Novel Microbial Phenotypes
Minjeong Kang, Kangsan Kim and Byung-Kwan Cho
8 Enzymatic Preparation of DNA with an Expanded Genetic Alphabet Using Terminal Deoxynucleotidyl Transferase and Its Applications
Guangyuan Wang, Yuhui Du and Tingjian Chen
9 Single-Nucleotide Microbial Genome Editing Using CRISPRCas12a
Ho Joung Lee and Sang Jun Lee
10 Multiplex Marker-Less Genome Integration in Pichia pastoris Using CRISPR/Cas9
Jucan Gao, Jintao Cheng and Jiazhang Lian
11 Genome Editing, Transcriptional Regulation, and Forward Genetic Screening Using CRISPR-Cas12a Systems in Yarrowia lipolytica
Adithya Ramesh, Sangcheon Lee and Ian Wheeldon
12 An Improved Method for Eliminating or Creating Intragenic Bacterial Promoters
Ellina Tro imova, Dominic Y. Logel and Paul R. Jaschke
13 Genetic Code Expansion in Pseudomonas putida KT2440
Tianyu Gao, Jiantao Guo and Wei Niu
14 Genome-Wide Screen for Enhanced Noncanonical Amino Acid Incorporation in Yeast
Briana R. Lino and James A. Van Deventer
15 Positive Selection Screens for Programmable Endonuclease Activity Using I-SceI
Michael A. Mechikoff, Kok Zhi Lee and Kevin V. Solomon
16 CRISPR-Cas9-Mediated Genome Editing in Paenibacillus polymyxa
Giulia Ravagnan, Meliawati Meliawati and Jochen Schmid
Part III Genome Language and Computing
17 Programming Juxtacrine-Based Synthetic Signaling Networks in a Cellular Potts Framework
Calvin Lam and Leonardo Morsut
18 Encoding Genetic Circuits with DNA Barcodes Paves the Way for High-Throughput Pro iling of Dose-Response Curves of Metabolite Biosensors
Huibao Feng, Yikang Zhou and Chong Zhang
19 Machine Learning for Biological Design
Tom Blau, Iadine Chades and Cheng Soon Ong
20 A Machine Learning Approach for Predicting Essentiality of Metabolic Genes
Lilli J. Freischem and Diego A. Oyarzun
21 The Causes for Genomic Instability and How to Try and Reduce Them Through Rational Design of Synthetic DNA
Matan Arbel-Groissman, Itamar Menuhin-Gruman, Hader Yehezkeli, Doron Naki, Shaked Bergman, Yarin Udi and Tamir Tuller
22 Genetic Network Design Automation with LOICA
Gonzalo Vidal, Carolus Vitalis, Tamara Matute, Isaac Nunez, Fernan Federici and Timothy J. Rudge
23 Flapjack: Data Management and Analysis for Genetic Circuit Characterization
Carolus Vitalis, Guillermo Yanez Feliu, Gonzalo Vidal, Macarena Munoz Silva, Tamara Matute, Isaac Nunez, Fernan Federici and Timothy J. Rudge
Part IV Molecular Assembly
24 In Vivo DNA Assembly Using the PEDA Method
Tianyuan Su, Qingxiao Pang and Qingsheng Qi
25 Cell-Free Synthesis and Quantitation of Bacteriophages
Antoine Levrier, Steven Bowden, Bruce Nash, Ariel Lindner and Vincent Noireaux
26 Multimodal Control of Bacterial Gene Expression by Red and Blue Light
Stefanie S. M. Meier, Elina Multamaki, Americo T. Ranzani, Heikki Takala and Andreas Moglich
27 In Silico Design, In Vitro Construction, and In Vivo Application of Synthetic Small Regulatory RNAs in Bacteria
Michel Bruck, Bork A. Berghoff and Daniel Schindler Index
Contributors
Matan Arbel-Groissman
Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Michael Dare Asemoloye
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China
Bork A. Berghoff
Institute for Microbiology and Molecular Biology, Justus-Liebig
University Giessen, Giessen, Germany
Shaked Bergman
Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, Israel
Priyan Bhattacharya
Department of Chemical Engineering, Indian Institute of Technology, Madras (IIT Madras), Chennai, India
Robert Bosch Centre of Data Science and Arti icial Intelligence (RBCDSAI), IIT Madras, Chennai, India
Initiative for Biological Science and Systems mEdicine (IBSE), IIT Madras, Chennai, India
Jacob D. Bibik
Department of Biochemistry, Michigan State University, East Lansing, USA
MelaTech, LLC, Baltimore, Maryland, USA
Tom Blau
CSIRO, Data 61, Eveleigh, NSW, Australia
Steven Bowden
University of Minnesota, Department of Food Science and Nutrition, Saint Paul, MN, USA
Michel Brück
Max Planck Institute for Terrestrial Microbiology, Marburg, Germany
Institute for Microbiology and Molecular Biology, Justus-Liebig University Giessen, Giessen, Germany
Abigail E. Bryson
Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI, USA
Iadine Chades
CSIRO, Environment, Brisbane, QLD, Australia
Jintao Cheng
Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China
ZJU-Hangzhou Global Scienti ic and Technological Innovation Center, Zhejiang University, Hangzhou, China
Lei Chen
Laboratory of Synthetic Microbiology, School of Chemical Engineering & Technology, Tianjin University, Tianjin, People’s Republic of China
Key Laboratory of Systems Bioengineering and Frontier Science Center of Synthetic Biology, the Ministry of Education of China, Tianjin University, Tianjin, People’s Republic of China
Tingjian Chen
MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, P. R. China
Byung-Kwan Cho
Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
Innovative Biomaterials Research Center, KI for the BioCentury, Korea
Advanced Institute of Science and Technology, Daejeon, Republic of Korea
Intelligent Synthetic Biology Center, Daejeon, Republic of Korea
Yuhui Du
MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China
University of Technology, Guangzhou, P. R. China
Fernán Federici
ANID-Millennium Science Initiative Program Millennium Institute for Integrative Biology (iBio), Santiago, Chile
FONDAP Center for Genome Regulation, Santiago, Chile
Institute for Biological and Medical Engineering Schools of Engineering, Medicine and Biological Sciences Ponti icia Universidad Catolica de Chile, Santiago, Chile
Guillermo Yáñez Feliú
Interdisciplinary Computing and Complex Biosystems, School of Computing, Newcastle University, Newcastle upon Tyne, UK
Huibao Feng
MOE Key Laboratory for Industrial Biocatalysis, Institute of Biochemical Engineering, Department of Chemical Engineering, Tsinghua University, Beijing, China
Lilli J. Freischem
Department of Physics, University of Oxford, Oxford, UK
Jucan Gao
Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China
ZJU-Hangzhou Global Scienti ic and Technological Innovation Center, Zhejiang University, Hangzhou, China
Tianyu Gao
Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA
Jiantao Guo
Department of Chemistry, University of Nebraska-Lincoln, Lincoln, Nebraska, USA
The Nebraska Center for Integrated Biomolecular Communication (NCIBC), University of Nebraska-Lincoln, Lincoln, Nebraska, USA
Björn Hamberger
Department of Biochemistry, Michigan State University, East Lansing, USA
Paul R. Jaschke
School of Natural Sciences, Macquarie University, Sydney, New South Wales, Australia
ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, Australia
Yue Ju
Laboratory of Synthetic Microbiology, School of Chemical Engineering & Technology, Tianjin University, Tianjin, People’s Republic of China
Key Laboratory of Systems Bioengineering and Frontier Science Center of Synthetic Biology, the Ministry of Education of China, Tianjin University, Tianjin, People’s Republic of China
Minjeong Kang
Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
Kangsan Kim
Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
Calvin Lam
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA
Ho Joung Lee
Department of Systems Biotechnology, and Institute of Microbiomics, Chung-Ang University, Anseong, Republic of Korea
Kok Zhi Lee
Department of Energy, Environmental & Chemical Engineering, Washington University at St. Louis, St. Louis, MO, USA
Sang Jun Lee
Department of Systems Biotechnology, and Institute of Microbiomics, Chung-Ang University, Anseong, Republic of Korea
Sangcheon Lee
Department of Chemical and Environmental Engineering, University of California, Riverside, USA
Antoine Levrier
Universite de Paris, INSERM U1284, Center for Research and Interdisciplinarity (CRI), Paris, France
University of Minnesota, Physics and Nanotechnology, Minneapolis, MN, USA
Jiazhang Lian
Key Laboratory of Biomass Chemical Engineering of Ministry of Education, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, China
ZJU-Hangzhou Global Scienti ic and Technological Innovation Center, Zhejiang University, Hangzhou, China
Zhejiang Key Laboratory of Smart Biomaterials, Zhejiang University, Hangzhou, China
Ariel Lindner
Universite de Paris, INSERM U1284, Center for Research and Interdisciplinarity (CRI), Paris, France
Briana R. Lino
Chemical and Biological Engineering Department, Tufts University, Medford, MA, USA
Dominic Y. Logel
School of Natural Sciences, Macquarie University, Sydney, New South Wales, Australia
ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, Australia
Mario Andrea Marchisio
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China
Tamara Matúte
ANID-Millennium Science Initiative Program Millennium Institute for Integrative Biology (iBio), Santiago, Chile
FONDAP Center for Genome Regulation, Santiago, Chile
Institute for Biological and Medical Engineering Schools of Engineering, Medicine and Biological Sciences Ponti icia Universidad Catolica de Chile, Santiago, Chile
Michael A. Mechikoff
Department of Biology, US Air Force Academy, Colorado Springs, CO, USA
Stefanie S. M. Meier
Department of Biochemistry, University of Bayreuth, Bayreuth, Germany
Meliawati Meliawati
Institute of Molecular Microbiology and Biotechnology, University of Munster, Munster, Germany
Itamar Menuhin-Gruman
School of Mathematical Sciences, The Raymond and Beverly Sackler
Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel
Andreas Möglich
Department of Biochemistry, University of Bayreuth, Bayreuth, Germany
Bayreuth Center for Biochemistry and Molecular Biology, Universitat Bayreuth, Bayreuth, Germany
North-Bavarian NMR Center, Universitat Bayreuth, Bayreuth, Germany
Leonardo Morsut
The Eli and Edythe Broad CIRM Center, Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA
Elina Multamäki
Department of Anatomy, University of Helsinki, Helsinki, Finland
Doron Naki
Shmunis School of Biomedicine and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
Bruce Nash
Cold Spring Harbor Laboratory, DNA Learning Center, Cold Spring Harbor, NY, USA
Wei Niu
Department of Chemical & Biomolecular Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska, USA
The Nebraska Center for Integrated Biomolecular Communication (NCIBC), University of Nebraska-Lincoln, Lincoln, Nebraska, USA
Vincent Noireaux
University of Minnesota, Physics and Nanotechnology, Minneapolis, MN, USA
Isaac Núñez
ANID-Millennium Science Initiative Program Millennium Institute for Integrative Biology (iBio), Santiago, Chile
FONDAP Center for Genome Regulation, Santiago, Chile
Institute for Biological and Medical Engineering Schools of Engineering, Medicine and Biological Sciences Ponti icia Universidad Catolica de Chile, Santiago, Chile
Cheng Soon Ong
CSIRO, Data 61, Canberra, ACT, Australia
Diego A. Oyarzún
School of Informatics, University of Edinburgh, Edinburgh, UK
School of Biological Sciences, University of Edinburgh, Edinburgh, UK
The Alan Turing Institute, London, UK
Qingxiao Pang
Shandong Lishan Biotechnology Co. LTD, Jinan, People’s Republic of China
Qingsheng Qi
State Key Laboratory of Microbial Technology, Shandong university, Qingdao, People’s Republic of China
Karthik Raman
Bhupat and Jyoti Mehta School of Biosciences, IIT Madras, Chennai, India
Robert Bosch Centre of Data Science and Arti icial Intelligence (RBCDSAI), IIT Madras, Chennai, India
Initiative for Biological Science and Systems mEdicine (IBSE), IIT Madras, Chennai, India
Adithya Ramesh
Department of Chemical and Environmental Engineering, University of California, Riverside, USA
Américo T. Ranzani
Department of Biochemistry, University of Bayreuth, Bayreuth, Germany
Giulia Ravagnan
Institute of Molecular Microbiology and Biotechnology, University of Munster, Munster, Germany
Timothy J. Rudge
Interdisciplinary Computing and Complex Biosystems, School of Computing, Newcastle University, Newcastle upon Tyne, UK
Daniel Schindler
Max Planck Institute for Terrestrial Microbiology, Marburg, Germany
Center for Synthetic Microbiology (SYNMIKRO), Philipps-University Marburg, Marburg, Germany
Jochen Schmid
Institute of Molecular Microbiology and Biotechnology, University of Munster, Munster, Germany
Macarena Muñoz Silva
Interdisciplinary Computing and Complex Biosystems, School of Computing, Newcastle University, Newcastle upon Tyne, UK
Kevin V. Solomon
Department of Chemical & Biomolecular Engineering, University of Delaware, Newark, DE, USA
Xinyu Song
Laboratory of Synthetic Microbiology, School of Chemical Engineering & Technology, Tianjin University, Tianjin, People’s Republic of China
Key Laboratory of Systems Bioengineering and Frontier Science Center of Synthetic Biology, the Ministry of Education of China, Tianjin University, Tianjin, People’s Republic of China
Center for Biosafety Research and Strategy, Tianjin University, Tianjin, People’s Republic of China
Tianyuan Su
State Key Laboratory of Microbial Technology, Shandong university, Qingdao, People’s Republic of China
Heikki Takala
Department of Anatomy, University of Helsinki, Helsinki, Finland
Department of Biological and Environmental Science, Nanoscience Center, University of Jyvaskyla, Jyvaskyla, Finland
Arun K. Tangirala
Department of Chemical Engineering, Indian Institute of Technology, Madras (IIT Madras), Chennai, India
Robert Bosch Centre of Data Science and Arti icial Intelligence (RBCDSAI), IIT Madras, Chennai, India
Initiative for Biological Science and Systems mEdicine (IBSE), IIT Madras, Chennai, India
Ellina Tro imova
School of Natural Sciences, Macquarie University, Sydney, New South Wales, Australia
ARC Centre of Excellence in Synthetic Biology, Macquarie University, Sydney, Australia
Tamir Tuller
Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, Israel
The Sagol School of Neuroscience, Tel-Aviv University, Tel Aviv, Israel
Yarin Udi
Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, Israel
James A. Van Deventer
Chemical and Biological Engineering Department, Tufts University, Medford, MA, USA
Biomedical Engineering Department, Tufts University, Medford, MA, USA
Gonzalo Vidal
Interdisciplinary Computing and Complex Biosystems, School of Computing, Newcastle University, Newcastle upon Tyne, UK
Carolus Vitalis
Department of Electrical, Computer, and Energy Engineering, University of Colorado Boulder, Boulder, Colorado, USA
Guanyuan Wang
MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, P. R. China
Ian Wheeldon
Department of Chemical and Environmental Engineering, University of California, Riverside, USA
Hader Yehezkeli
Department of Biomedical Engineering, Tel Aviv University, Tel Aviv, Israel
Lifang Yu
School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China
Chong Zhang
MOE Key Laboratory for Industrial Biocatalysis, Institute of Biochemical Engineering, Department of Chemical Engineering, Tsinghua University, Beijing, China
Center for Synthetic and Systems Biology, Tsinghua University, Beijing, China
Weiwen Zhang
Laboratory of Synthetic Microbiology, School of Chemical Engineering & Technology, Tianjin University, Tianjin, People’s Republic of China
Key Laboratory of Systems Bioengineering and Frontier Science Center of Synthetic Biology, the Ministry of Education of China, Tianjin University, Tianjin, People’s Republic of China
Center for Biosafety Research and Strategy, Tianjin University, Tianjin, People’s Republic of China
Yikang Zhou
MOE Key Laboratory for Industrial Biocatalysis, Institute of Biochemical Engineering, Department of Chemical Engineering, Tsinghua University, Beijing, China
1. Plant Engineering to Enable Platforms for Sustainable Bioproduction of Terpenoids
Jacob D. Bibik1, 2 and Bjorn Hamberger1
(1) (2)
Department of Biochemistry, Michigan State University, East Lansing, MI, USA
MelaTech, LLC, Baltimore, MD, USA
Björn Hamberger
Email: hamberge@msu.edu
Abstract
Terpenoids represent the most diverse class of natural products, with a broad spectrum of industrial relevance including applications in green solvents, lavors and fragrances, nutraceuticals, colorants, and therapeutics. They are typically challenging to extract from their natural sources, where they occur in small amounts and mixtures of related but unwanted byproducts. Formal chemical synthesis, where established, is reliant on petrochemistry. Hence, there is great interest in developing sustainable solutions to assemble biosynthetic pathways in engineered host organisms. Metabolic engineering for chemical production has largely focused on microbial hosts, yet plants offer a sustainable production platform. In addition to containing the precursor pathways that generate the terpenoid building blocks as well as the cell structures and compartments required, or tractable localization for the enzymes involved, plants may provide a low input system to produce these chemicals using carbon dioxide and sunlight
only. There have been signi icant recent advancements in the discovery of pathways to terpenoids of interest as well as strategies to boost yields in host plants. While part of the phytochemical ield is focusing on the discovery of biosynthetic pathways, this review will focus on advancements using the pathway toolbox and toward engineering plants for the production of terpenoids. We will highlight strategies currently used to produce target products, optimization of known pathways to improve yields, compartmentalization of pathways within cells, and genetic tools developed to facilitate complex engineering of biosynthetic pathways. These advancements in Synthetic Biology are bringing engineered plant systems closer to commercially relevant hosts for the bioproduction of terpenoids.
Key words Terpene – Engineering – Terpene synthase – Synthetic biology – Metabolic engineering – Bioproduction –Compartmentalization – Regulation.
1 Introduction
Plants contain enormous chemical diversity, which humans have been recognizing for thousands of years, especially from traditionally medicinal plants [1–3]. Since the earliest plants with highly limited terpene diversity began to colonize the land [4], this diversity has exploded as rapidly speciating plants have evolved an array of specialized metabolites, with roles in adaptation and response to various environmental conditions, both biotic and abiotic, as well as signaling and communication. An estimated number of more than 1 million unique metabolites is produced across all plants [5, 6], which establishes them as excellent natural product factories. This potential can be further expanded onthrough engineering for biotechnological applications [7, 8]. Terpenes, and the further functionalized terpenoids, are a particularly diverse group of natural products with 66,650 of the total 86,000 reported structures identi ied in plants, according to the Dictionary of Natural Products (Dictionary of Natural Products 31.1, https://dnp.chemnetbase.com/ accessed 9/2022). While terpenoids have important roles within central metabolism across plant species, the majority have evolved as specialized metabolites, often only found
in speci ic plant lineages or species [9–11]. The expansive chemical diversity of terpenes and terpenoids far surpasses their known roles in plants [12]. Yet, these speci ic natural product-accumulating plants have been exploited throughout human history as culinary herbs and spices, medicinal plants, for resins, and other traditional applications [13]. The current global market for terpene lavor and fragrances (C10–C30) is expected to reach nearly $5B by 2024 with an annual increase in demand of 5.2% [14].
There has been growing interest in advancing synthetic biology approaches to engineer plants into chemical factories through engineering of biosynthetic pathways for terpenoids important to modern society, while even further expanding beyond naturally occurring terpenoid chemistry [9, 11, 15–17]. The discovery and installation of these biosynthetic pathways have enabled the production of not only natural terpenoids but also the creation of newto-nature structures by combining modular pathways [18–20]. Much of the success in plant engineering has involved simple pathways, i.e., short terpene pathways, but strategies are being developed to build multigene complex pathways by controlling how, where, and when terpenoids are produced within plants. In addition to the innovations with pathway engineering, there have been advancements in genetic engineering tools. Yet, to enable the engineering of longer and more complex pathways beyond terpene synthases, i.e., downstream enzymes responsible for the functionalization and decoration of terpene scaffolds, advanced tools will be needed. Here, we review recent strategies to engineer plants for the production of terpenoids, optimization of biosynthetic pathways and carbon lux, compartmentalization of pathways and products, and advancements in genetic tools to build plant hosts with increasingly larger and more complex pathways.
2 Terpenoid Production in Plants
Terpenoids are universally found across all kingdoms of life and are formed from common C5 building blocks. These building blocks, isopentenyl diphosphate (IDP) and dimethylallyl diphosphate (DMADP), are isomers synthesized via two pathways that are both
present in plants, although most non-plant organisms contain only one. The mevalonate (MVA) pathway, which is commonly found in eukaryotic organisms, synthesizes a cytosolic pool of IDP/DMADP starting with condensation of three acetyl-CoA molecules in two enzymatic steps to form 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA). HMG-CoA is then reduced by HMG-CoA reductase (HMGR) to form mevalonate, the dedicated step to the MVA pathway. The methylerythritol 4-phosphate (MEP) pathway, often found in prokaryotic organisms and characteristic of plant plastids, synthesizes a pool of IDP/DMADP, which begins with the condensation of pyruvate and glyceraldehyde 3-phosphate (GAP). This reaction forms 1-deoxy-dxylulose-5-phosphate (DXP) and is catalyzed by DXP synthase (DXS). In addition to this natural compartmentalization of IDP/DMADP accumulation, the enzymes involved in the immediate terpene precursor and scaffold biosynthesis are also co-localized to access the respective building block pools in each compartment. Typically localized to plastids are the diphosphate synthases, which form the C10 geranyl diphosphate (GDP) or the C20 geranylgeranyl diphosphate (GGDP) through condensation of two or four IDP/DMADP molecules by GDP synthase or GGDP synthase (GGDPS), respectively. Furthermore, mono- and di-terpene synthases co-localized to plastids utilize GDP and GGDP to synthesize the C10 mono- and C20 diterpenes, respectively. Some plants are native emitters of the C5 hemiterpene isoprene and contain an isoprene synthase (ISPS), which also typically resides in the plastid. Cytosolically, three IDP/DMADP molecules form the C15 intermediate farnesyl diphosphate (FDP) through condensation by FDP synthase (FDPS), which serves as the substrate for sesquiterpene synthases to synthesize sesquiterpenes. Localized to the endoplasmic reticulum is squalene synthase (SQS), which condenses two FDP molecules to form the C30 squalene, which is the precursor to sterols and triterpenoids.
There have been many research efforts to understand and engineer these pathways while developing hosts for biosynthesis of terpenoids as direct products and intermediates in semi-chemical synthesis, e.g., refs [21–23]. In some instances, plant species that are known to synthesize particular terpenoids have been manipulated to enable
larger-scale production. For example, the diterpene (-)-sclareol from Salvia sclarea (clary sage) is commonly extracted as an intermediate of the semi-chemical synthesis of ambroxide, a high-value product used in the fragrance industry [24]. Ambroxide was historically extracted from sperm whale ambergris but the biosynthetic pathway is unknown, although bacterial pathways have recently been engineered to synthesize the triterpenoid precursor, ambrein, of which ambroxide is an oxidized product [25, 26]. In another example, plant tissue culture techniques were developed as the production platform for paclitaxel, a complex diterpenoid found in yew trees (Taxus spp.) [27]. Under standard growth conditions, paclitaxel was not produced at industrially relevant yields, but the development and optimization of tissue culture enabled ef icient production for the compound to become widely used in chemotherapeutics. While these examples demonstrate the ingenuity to produce high-value terpenoids from native species, this is not feasible for most plants or terpenoids. To this end, engineering plants with speci ic biosynthetic pathways and strategies to optimize yields has become a focus in synthetic biology and will be in line with developing the potential of plants for a sustainable future [28].
While microbial fermentation is often used for the production of chemicals like terpenoids, engineered plants present an opportunity for a low-input chassis system by utilizing sunlight and CO2 to produce large amounts of biomass [29, 30]. This can be especially effective in high biomass producing, non-food crops, which can be grown on marginal lands not suitable for food crops. Additionally, plants already contain cellular structures, co-enzymes, and precursor pathways to support the production of many natural products. There are many examples of effective plant engineering to produce valuable terpenoids with biotechnological importance. A broad spectrum of terpenoid pathways has been engineered in tobacco (Nicotiana spp.), which has become extensively used due to the ease of generating transgenic plants, as well as transient expression system to rapidly test pathways [11, 15–17, 19, 31–36]. Other model plants have also been used for terpenoid production, including tomato [37], Arabidopsis [38, 39], Camelina [40], and even moss [4, 41].
These platforms have been employed to produce volatile terpenoids including the hemiterpene isoprene [33], monoterpenoids [15, 38, 39],
and sesquiterpenoids [40, 41], many of which are commonly used in the lavor and fragrance industry. The longer chain, non-volatile terpenoids have also been of great interest, including combinatorial strategies to expand the number of diterpenoids that can be produced in planta [11, 19, 42] and have potential roles in a range of industries. Additionally, there have been efforts to engineer the production of squalene as well as downstream triterpenoids and sterols, which have applications in cosmetic oils, biofuels, or pharmaceuticals [16, 17, 35]. Finally, there has been a focus on engineering tetraterpenoids and, in particular, carotenoids, which are of interest as natural pigments and nutritional additives [32, 36]. While many studies have enabled the synthesis of an array of terpenoids, they often result in low yields because they are not optimized for production, with deleterious effects on the products and the misbalance of native metabolism as well. We will next discuss strategies to improve production in plant hosts, through pathway optimization and compartmentalization.
3 Engineering Strategies to Improve the Bioproduction of Terpenoids in Plants
Approaches have been developed to increase metabolic lux toward desired terpenoids including overexpression of key bottlenecks in the MEP/MVA pathways, engineering de-regulated variants of enzymes, e.g., a truncated HMGR, or mutated DXS [43, 44], incorporation of alternative contributors to in luence IDP/DMADP pools [38, 39, 45], and silencing of competing pathways [34]. Each of these approaches either improves the availability of or redirects IDP/DMADP for the production of desired terpenoids. For example, overexpression of ratelimiting steps of the MVA or MEP pathways, HMGR and DXS, enables signi icant increases in terpenoids by increasing metabolic lux toward IDP/DMADP [45–48]. These enzymes have also been targeted for engineering to reduce feedback inhibition from the end products IDP and DMADP [43, 44]. Other strategies have been developed via alternative contributions to the MVA/MEP pathways or IDP/DMADP formation directly. One set of enzymes, phosphomevalonate decarboxylase (MPD) and isopentenyl phosphate kinase (IPK), were used to recreate an archaeal pathway in plants, which performs the